World's Best Scientists 2026 revealed!
Haralambos Gavras

Haralambos Gavras

D-Index & Metrics

Medicine

D-Index
73
Citations
19298
World Ranking
19657
National Ranking
9790

Haralambos Gavras publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Haralambos Gavras sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 396 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Haralambos Gavras D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Haralambos Gavras sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 73 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Haralambos Gavras is a researcher affiliated with Boston University in the United States, specializing in the field of Medicine. Their work spans multiple subfields, including Genetics, Cancer Research, Oncology, and Nutrition and Dietetics.

Their research contributions are documented in several peer-reviewed publications. Notable recent papers include:

  • Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?, 2020, European Journal of Medicinal Chemistry
  • Abstract P109: A Promising Novel Hypertension Drug Candidate, 2021, Hypertension

Gavras's research topics cover biochemical and physiological mechanisms related to health and disease. The main themes they focus on include:

  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Protease and Inhibitor Mechanisms
  • Peptidase Inhibition and Analysis
  • Magnesium in Health and Disease

Collaborations are an important aspect of Gavras's research. Frequent coauthors include Gerasimos Rassias, Sofia Leonardi, Dionisia Rigopoulou, Eleanna Vachlioti, and Konstantinos Afratis. These collaborative efforts contribute to multidisciplinary approaches within the studied topics.

Their work has been published primarily in venues such as the European Journal of Medicinal Chemistry and Hypertension, reflecting a focus on medicinal chemistry and cardiovascular research fields.

Best Publications

  • Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in Man

    Haralambos Gavras;Hans R. Brunner;Gustave A. Turini;Glenn R. Kershaw

  • Evidence for a Gene Influencing Blood Pressure on Chromosome 17: Genome Scan Linkage Results for Longitudinal Blood Pressure Phenotypes in Subjects From the Framingham Heart Study

    Daniel Levy;Anita L. DeStefano;Martin G. Larson;Christopher J. O’Donnell

  • Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

    Hans R. Brunner;Haralambos Gavras;Bernard Waeber;Glen R. Kershaw

  • An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.

    Haralambos Gavras;Hans R. Brunner;John H. Laragh;Jean E. Sealey

  • The A2B adenosine receptor protects against inflammation and excessive vascular adhesion

    Dan Yang;Ying Zhang;Hao G. Nguyen;Milka Koupenova

  • Insulin Infusion in Conscious Dogs: EFFECTS ON SYSTEMIC AND CORONARY HEMODYNAMICS, REGIONAL BLOOD FLOWS, AND PLASMA CATECHOLAMINES

    Chang-Seng Liang;John U. Doherty;Robert Faillace;Kishio Maekawa

  • ANGIOTENSIN-II BLOCKADE IN MAN BY SAR1-ALA8-ANGIOTENSIN II FOR UNDERSTANDING AND TREATMENT OF HIGH BLOOD-PRESSURE

    H.R. Brunner;H. Gavras;J.H. Laragh;R. Keenan

  • Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade.

    Jerôme Biollaz;Hans R. Brunner;Irène Gavras;Bernard Waeber

  • Angiotensin converting enzyme inhibition in patients with congestive heart failure.

    H Gavras;D P Faxon;J Berkoben;H R Brunner

  • Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci.

    Fumihiro Sugiyama;Gary A. Churchill;David C. Higgins;Conrado Johns

  • Muscle glycogenolysis during exercise: dual control by epinephrine and contractions

    E. A. Richter;N. B. Ruderman;H. Gavras;E. R. Belur

  • Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.

    Mark A. Creager;David P. Faxon;Sally S. Cutler;Osvaldo Kohlmann

  • ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421".

    Haralambos Gavras;Bernard Waeber;Irene Gavras;Jerome Biollaz

  • Mineralocorticoid-Induced Hypertension in Patients with Orthostatic Hypotension

    Aram V. Chobanian;Ladislav Volicer;Charles P. Tifft;Haralambos Gavras

  • IMPROVEMENT OF CHRONIC CONGESTIVE HEART-FAILURE BY ORAL CAPTOPRIL

    GustaveA. Turini;HansR. Brunner;Milan Gribic;Bernard Waeber

  • Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.

    M A Creager;J L Halperin;D B Bernard;D P Faxon

  • Models of Experimental Hypertension in Mice

    Conrado Johns;Irene Gavras;Diane E. Handy;Abrahao Salomao

  • Renal Revascularization in the Azotemic Hypertensive Patient Resistant to Therapy

    Christopher Y. Ying;Charles P. Tifft;Haralambos Gavras;Aram V. Chobanian

  • Vasoactive Potential of the B1 Bradykinin Receptor in Normotension and Hypertension

    Irena Duka;Ekaterina Kintsurashvili;Irene Gavras;Conrado Johns

  • Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.

    Bernard Waeber;Han S R. Brunner;Dorette B. Brunner;Anne-Lis E Curtet

Frequent Co-Authors

Hans R. Brunner
Hans R. Brunner University of Lausanne
Bernard Waeber
Bernard Waeber University of Lausanne
John H. Laragh
John H. Laragh Cornell University
Diane E. Handy
Diane E. Handy Brigham and Women's Hospital
Clinton T. Baldwin
Clinton T. Baldwin Boston University
David P. Faxon
David P. Faxon Brigham and Women's Hospital
Anita L. DeStefano
Anita L. DeStefano Boston University
Thomas J. Ryan
Thomas J. Ryan Cincinnati Children's Hospital Medical Center
Lindsay A. Farrer
Lindsay A. Farrer Boston University
Vassilis I. Zannis
Vassilis I. Zannis Boston University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn't always mean following the traditional path to becoming a doctor. The healthcare sector offers a variety of flexible online degrees and career pathways, ideal for diverse professional goals and busy schedules.

For nurses with an associate degree, asn to nurse practitioner programs provide a direct route to advanced practice without needing to complete a full bachelor’s program first. If your interests are in nutrition and wellness, consider a nutritionist online degree that can help you specialize in dietary planning, public health, and counseling from home.

For those aiming for healthcare administration roles, whats the best online mha program for working adults is a useful guide to flexible, accredited programs that fit busy lifestyles. Registered nurses looking to advance their credentials can explore rn to bsn online with no clinicals, offering academic advancement without additional in-person requirements.

These options make it easier than ever to upgrade your skills and pursue a rewarding healthcare career through online study.

Best Scientists Citing Haralambos Gavras

Trending Scientists

Recently Published Articles